Continuous Versus Intermittent Infusion of Furosemide in Acute Decompensated Heart Failure
Despite advances in the treatment of chronic ambulatory heart failure, hospitalization rates for acute decompensated heart failure (ADHF) remain high. Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined. Th...
Uložené v:
| Vydané v: | Journal of cardiac failure Ročník 16; číslo 3; s. 188 - 193 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Elsevier Inc
01.03.2010
|
| Predmet: | |
| ISSN: | 1071-9164, 1532-8414, 1532-8414 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Despite advances in the treatment of chronic ambulatory heart failure, hospitalization rates for acute decompensated heart failure (ADHF) remain high. Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined.
This was a prospective, randomized, parallel-group study comparing the effectiveness of continuous intravenous (cIV) with intermittent intravenous (iIV) infusion of furosemide in 56 patients with ADHF. The dose and duration of furosemide as well as concomitant medications to treat ADHF were determined by physician preference. The primary end point of the study was net urine output (nUOP)/24hours. Safety measures including electrolyte loss and hemodynamic instability were also assessed.
Twenty-six patients received cIV and 30 patients received iIV dosing. The mean nUOP/24hours was 2098±1132mL in patients receiving cIV versus 1575±1100mL in the iIV group (P=.086). The cIV group had significantly greater total urine output (tUOP) with 3726±1121mL/24hours versus 2955±1267mL/24hours in the iIV group (P=.019) and tUOP/mg furosemide with 38.0±31.0mL/mg versus 22.2±12.5mL/mg (P=.021). Mean weight loss was not significantly different between the groups. The cIV group experienced a shorter length of hospital stay (6.9±3.7 versus 10.9±8.3 days, P=.006). There were no differences in safety measures between the groups.
The cIV of furosemide was well tolerated and significantly more effective than iIV for tUOP. In addition, continuous infusion appears to provide more efficient diuresis. |
|---|---|
| AbstractList | Despite advances in the treatment of chronic ambulatory heart failure, hospitalization rates for acute decompensated heart failure (ADHF) remain high. Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined.
This was a prospective, randomized, parallel-group study comparing the effectiveness of continuous intravenous (cIV) with intermittent intravenous (iIV) infusion of furosemide in 56 patients with ADHF. The dose and duration of furosemide as well as concomitant medications to treat ADHF were determined by physician preference. The primary end point of the study was net urine output (nUOP)/24hours. Safety measures including electrolyte loss and hemodynamic instability were also assessed.
Twenty-six patients received cIV and 30 patients received iIV dosing. The mean nUOP/24hours was 2098±1132mL in patients receiving cIV versus 1575±1100mL in the iIV group (P=.086). The cIV group had significantly greater total urine output (tUOP) with 3726±1121mL/24hours versus 2955±1267mL/24hours in the iIV group (P=.019) and tUOP/mg furosemide with 38.0±31.0mL/mg versus 22.2±12.5mL/mg (P=.021). Mean weight loss was not significantly different between the groups. The cIV group experienced a shorter length of hospital stay (6.9±3.7 versus 10.9±8.3 days, P=.006). There were no differences in safety measures between the groups.
The cIV of furosemide was well tolerated and significantly more effective than iIV for tUOP. In addition, continuous infusion appears to provide more efficient diuresis. Despite advances in the treatment of chronic ambulatory heart failure, hospitalization rates for acute decompensated heart failure (ADHF) remain high. Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined.BACKGROUNDDespite advances in the treatment of chronic ambulatory heart failure, hospitalization rates for acute decompensated heart failure (ADHF) remain high. Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined.This was a prospective, randomized, parallel-group study comparing the effectiveness of continuous intravenous (cIV) with intermittent intravenous (iIV) infusion of furosemide in 56 patients with ADHF. The dose and duration of furosemide as well as concomitant medications to treat ADHF were determined by physician preference. The primary end point of the study was net urine output (nUOP)/24 hours. Safety measures including electrolyte loss and hemodynamic instability were also assessed. Twenty-six patients received cIV and 30 patients received iIV dosing. The mean nUOP/24 hours was 2098+/-1132 mL in patients receiving cIV versus 1575+/-1100 mL in the iIV group (P=.086). The cIV group had significantly greater total urine output (tUOP) with 3726+/-1121 mL/24 hours versus 2955+/-1267 mL/24 hours in the iIV group (P=.019) and tUOP/mg furosemide with 38.0+/-31.0 mL/mg versus 22.2+/-12.5 mL/mg (P=.021). Mean weight loss was not significantly different between the groups. The cIV group experienced a shorter length of hospital stay (6.9+/-3.7 versus 10.9+/-8.3 days, P=.006). There were no differences in safety measures between the groups.METHODS AND RESULTSThis was a prospective, randomized, parallel-group study comparing the effectiveness of continuous intravenous (cIV) with intermittent intravenous (iIV) infusion of furosemide in 56 patients with ADHF. The dose and duration of furosemide as well as concomitant medications to treat ADHF were determined by physician preference. The primary end point of the study was net urine output (nUOP)/24 hours. Safety measures including electrolyte loss and hemodynamic instability were also assessed. Twenty-six patients received cIV and 30 patients received iIV dosing. The mean nUOP/24 hours was 2098+/-1132 mL in patients receiving cIV versus 1575+/-1100 mL in the iIV group (P=.086). The cIV group had significantly greater total urine output (tUOP) with 3726+/-1121 mL/24 hours versus 2955+/-1267 mL/24 hours in the iIV group (P=.019) and tUOP/mg furosemide with 38.0+/-31.0 mL/mg versus 22.2+/-12.5 mL/mg (P=.021). Mean weight loss was not significantly different between the groups. The cIV group experienced a shorter length of hospital stay (6.9+/-3.7 versus 10.9+/-8.3 days, P=.006). There were no differences in safety measures between the groups.The cIV of furosemide was well tolerated and significantly more effective than iIV for tUOP. In addition, continuous infusion appears to provide more efficient diuresis.CONCLUSIONSThe cIV of furosemide was well tolerated and significantly more effective than iIV for tUOP. In addition, continuous infusion appears to provide more efficient diuresis. Abstract Background Despite advances in the treatment of chronic ambulatory heart failure, hospitalization rates for acute decompensated heart failure (ADHF) remain high. Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined. Methods and Results This was a prospective, randomized, parallel-group study comparing the effectiveness of continuous intravenous (cIV) with intermittent intravenous (iIV) infusion of furosemide in 56 patients with ADHF. The dose and duration of furosemide as well as concomitant medications to treat ADHF were determined by physician preference. The primary end point of the study was net urine output (nUOP)/24 hours. Safety measures including electrolyte loss and hemodynamic instability were also assessed. Twenty-six patients received cIV and 30 patients received iIV dosing. The mean nUOP/24 hours was 2098 ± 1132 mL in patients receiving cIV versus 1575 ± 1100 mL in the iIV group ( P = .086). The cIV group had significantly greater total urine output (tUOP) with 3726 ± 1121 mL/24 hours versus 2955 ± 1267 mL/24 hours in the iIV group ( P = .019) and tUOP/mg furosemide with 38.0 ± 31.0 mL/mg versus 22.2 ± 12.5 mL/mg ( P = .021). Mean weight loss was not significantly different between the groups. The cIV group experienced a shorter length of hospital stay (6.9 ± 3.7 versus 10.9 ± 8.3 days, P = .006). There were no differences in safety measures between the groups. Conclusions The cIV of furosemide was well tolerated and significantly more effective than iIV for tUOP. In addition, continuous infusion appears to provide more efficient diuresis. Despite advances in the treatment of chronic ambulatory heart failure, hospitalization rates for acute decompensated heart failure (ADHF) remain high. Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined. This was a prospective, randomized, parallel-group study comparing the effectiveness of continuous intravenous (cIV) with intermittent intravenous (iIV) infusion of furosemide in 56 patients with ADHF. The dose and duration of furosemide as well as concomitant medications to treat ADHF were determined by physician preference. The primary end point of the study was net urine output (nUOP)/24 hours. Safety measures including electrolyte loss and hemodynamic instability were also assessed. Twenty-six patients received cIV and 30 patients received iIV dosing. The mean nUOP/24 hours was 2098+/-1132 mL in patients receiving cIV versus 1575+/-1100 mL in the iIV group (P=.086). The cIV group had significantly greater total urine output (tUOP) with 3726+/-1121 mL/24 hours versus 2955+/-1267 mL/24 hours in the iIV group (P=.019) and tUOP/mg furosemide with 38.0+/-31.0 mL/mg versus 22.2+/-12.5 mL/mg (P=.021). Mean weight loss was not significantly different between the groups. The cIV group experienced a shorter length of hospital stay (6.9+/-3.7 versus 10.9+/-8.3 days, P=.006). There were no differences in safety measures between the groups. The cIV of furosemide was well tolerated and significantly more effective than iIV for tUOP. In addition, continuous infusion appears to provide more efficient diuresis. |
| Author | Nappi, Jean M. Dunn, Steven P. Hollis, Ian B. Rodgers, Jo E. Van Bakel, Adrian B. Thomson, Margaret R. |
| Author_xml | – sequence: 1 givenname: Margaret R. surname: Thomson fullname: Thomson, Margaret R. organization: Baptist Hospital, Saint Thomas Health Services, Nashville, TN – sequence: 2 givenname: Jean M. surname: Nappi fullname: Nappi, Jean M. organization: South Carolina College of Pharmacy, Charleston, SC – sequence: 3 givenname: Steven P. surname: Dunn fullname: Dunn, Steven P. organization: University of Kentucky Chandler Medical Center, Lexington, KY – sequence: 4 givenname: Ian B. surname: Hollis fullname: Hollis, Ian B. organization: University of North Carolina, School of Pharmacy and Hospitals, Chapel Hill, NC – sequence: 5 givenname: Jo E. surname: Rodgers fullname: Rodgers, Jo E. organization: University of North Carolina, School of Pharmacy and Hospitals, Chapel Hill, NC – sequence: 6 givenname: Adrian B. surname: Van Bakel fullname: Van Bakel, Adrian B. email: vanbakel@musc.edUTH organization: Medical University of South Carolina, Charleston, SC |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20206891$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkstqHDEQRUVwiO1JfsH0Lqtul_otCCFmkrENhizyWGQj1FIJNOmWJnoE_PdRM3YWXsRZVRXce6k60jk5sc4iIRcUKgq0v9xXUnilhZmrGoBVlFYA3QtyRrumLseWtie5h4GWjPbtKTkPYQ8AYwvDK3JaQw39yOgZ-bF1NhqbXArFd_Qhl1sb0S8mRrQxDzoF42zhdLFL3gVcjMLC2OJKpojFR5RuOaANIqIqblD4WOzyVsnja_JSizngm4e6Id92n75ub8q7z9e326u7UrbDEEsGHUMt9aTyOOlOI4xyFC1F1ahatRIGwSbBpKCsGbuu77tpaoamZZNmw6SaDXl7zD149ythiHwxQeI8C4v5LD40De1GyJYNuXhQpmlBxQ_eLMLf80ccWdAfBTJfGjzqvxIKfOXO9_yRO1-5c0p55p6N754YpYkiZnDRr9pn7R-Odsycfhv0PEiDVqIyHmXkypnnI94_iZCzsUaK-SfeY9i75G1-BU55qDnwL-vfWL8GMKC5Yf8O-J8N_gAlas3x |
| CitedBy_id | crossref_primary_10_1161_CIR_0b013e3181f9a223 crossref_primary_10_1016_j_tvjl_2018_07_001 crossref_primary_10_1016_j_mcna_2012_07_003 crossref_primary_10_1080_21548331_2021_1893065 crossref_primary_10_1093_ajhp_zxae059 crossref_primary_10_1177_0269216311399490 crossref_primary_10_1007_s11936_012_0186_5 crossref_primary_10_1371_journal_pone_0196088 crossref_primary_10_1056_NEJMoa1005419 crossref_primary_10_1016_j_repce_2014_08_018 crossref_primary_10_1590_1806_9282_20220583 crossref_primary_10_1111_anae_14038 crossref_primary_10_1002_ehf2_13286 crossref_primary_10_1016_j_ahj_2010_09_014 crossref_primary_10_1080_10826076_2012_712931 crossref_primary_10_1007_s10741_018_9727_7 crossref_primary_10_1159_000529068 crossref_primary_10_1177_2050312120940094 crossref_primary_10_1016_j_repc_2014_08_019 crossref_primary_10_1097_CNQ_0000000000000173 crossref_primary_10_1002_phar_1369 crossref_primary_10_1007_s00392_019_01521_y crossref_primary_10_1177_039493621202400120 crossref_primary_10_1016_j_amjms_2022_12_013 crossref_primary_10_1136_spcare_2022_003863 crossref_primary_10_2146_ajhp150023 crossref_primary_10_1016_j_mayocp_2014_01_004 crossref_primary_10_1016_j_cardfail_2019_11_013 crossref_primary_10_1097_MD_0000000000025669 crossref_primary_10_1007_s10557_013_6491_8 crossref_primary_10_1007_s10741_012_9354_7 crossref_primary_10_1177_0897190016645435 crossref_primary_10_1002_phar_1798 crossref_primary_10_1016_j_repc_2022_05_012 crossref_primary_10_1097_ACO_0b013e328347b491 crossref_primary_10_1007_s11897_012_0094_8 crossref_primary_10_1097_PCC_0000000000000303 crossref_primary_10_1007_s11739_014_1112_5 crossref_primary_10_1038_nrcardio_2014_215 crossref_primary_10_1016_j_jchf_2018_04_008 crossref_primary_10_1016_j_ehj_2017_12_005 crossref_primary_10_1016_j_cardfail_2017_06_008 crossref_primary_10_1177_0885066616669494 crossref_primary_10_7759_cureus_34758 crossref_primary_10_1097_ACO_0b013e3283462257 crossref_primary_10_1186_s43054_023_00225_3 crossref_primary_10_1186_cc13952 crossref_primary_10_1053_j_ajkd_2011_06_005 crossref_primary_10_1177_1074248413482755 crossref_primary_10_1002_jhm_991 crossref_primary_10_1016_j_jcrc_2013_10_009 crossref_primary_10_1155_2022_4627826 crossref_primary_10_1007_s11886_016_0801_2 crossref_primary_10_1177_1074248412446194 crossref_primary_10_1016_j_ihj_2014_03_006 crossref_primary_10_1016_j_jcrc_2013_03_015 crossref_primary_10_1002_ehf2_14168 crossref_primary_10_5049_EBP_2015_13_1_17 |
| Cites_doi | 10.3109/00365519709099409 10.1038/ki.1989.246 10.1161/CIRCHEARTFAILURE.108.821785 10.1016/j.cardfail.2005.11.017 10.1159/000047397 10.1345/aph.1G693 10.1016/0002-9610(83)90344-6 10.1016/0735-1097(96)00161-1 10.1016/S0022-3565(25)21252-6 10.1378/chest.102.3.725 10.1016/S0735-1097(03)00765-4 10.1002/14651858.CD003178.pub3 10.1002/j.1552-4604.1996.tb04197.x |
| ContentType | Journal Article |
| Copyright | 2010 Elsevier Inc. Elsevier Inc. Copyright (c) 2010 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2010 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright (c) 2010 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.cardfail.2009.11.005 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-8414 |
| EndPage | 193 |
| ExternalDocumentID | 20206891 10_1016_j_cardfail_2009_11_005 S1071916409011919 1_s2_0_S1071916409011919 |
| Genre | Randomized Controlled Trial Journal Article Comparative Study |
| GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HX~ HZ~ IHE J1W KOM M29 M41 MO0 N9A O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UHS WUQ Z5R ~G- ~HD AACTN AFCTW AFKWA AJOXV AMFUW RIG 9DU AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c477t-9059efcfbd477bf5fe08c8a41ed3d2d4c07a9ba9ca193855665bb37349bf97bd3 |
| ISICitedReferencesCount | 66 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000277582100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1071-9164 1532-8414 |
| IngestDate | Mon Sep 29 06:42:45 EDT 2025 Mon Jul 21 06:04:05 EDT 2025 Sat Nov 29 07:06:08 EST 2025 Tue Nov 18 21:46:54 EST 2025 Sun Apr 06 06:54:29 EDT 2025 Sun Feb 23 10:19:17 EST 2025 Tue Oct 14 19:31:40 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Diuretics furosemide heart failure |
| Language | English |
| License | Copyright (c) 2010 Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c477t-9059efcfbd477bf5fe08c8a41ed3d2d4c07a9ba9ca193855665bb37349bf97bd3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| PMID | 20206891 |
| PQID | 733158037 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_733158037 pubmed_primary_20206891 crossref_primary_10_1016_j_cardfail_2009_11_005 crossref_citationtrail_10_1016_j_cardfail_2009_11_005 elsevier_sciencedirect_doi_10_1016_j_cardfail_2009_11_005 elsevier_clinicalkeyesjournals_1_s2_0_S1071916409011919 elsevier_clinicalkey_doi_10_1016_j_cardfail_2009_11_005 |
| PublicationCentury | 2000 |
| PublicationDate | 2010-03-01 |
| PublicationDateYYYYMMDD | 2010-03-01 |
| PublicationDate_xml | – month: 03 year: 2010 text: 2010-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of cardiac failure |
| PublicationTitleAlternate | J Card Fail |
| PublicationYear | 2010 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Kramer, Smith, Ferguson, Serpas, Grant, Black (bib15) 1996; 36 Fonarow (bib2) 2003; 4 Domanski, Norman, Pitt, Haigney, Hanlon, Peyster (bib3) 2003; 42 Aaser, Gullestad, Tollofsrud, Lundberg, Hall, Djoseland (bib16) 1997; 57 Ellison (bib10) 2001; 96 Hammarlund, Odlind, Paalzow (bib11) 1985; 233 Lahav, Regev, Ra'anani, Theodor (bib13) 1992; 102 Dormans, VanMeyel, Gerlag, Tan, Russel, Smiths (bib7) 1996; 28 Felker, O'Connor, Braunwald (bib9) 2009; 2 American Heart Association, American Stroke Association. Heart disease and stroke statistics—2008 update. Available from Salvador DRK, Rey NR, Ramos GC, Punzalan FER. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003178. DOI: 10.1002/14651858.CD003178.pub3 (bib4) 2006; 12 Gulbis, Spencer (bib6) 2006; 40 Pivac, Rumboldt, Sardelic, Bagatin, Polic, Ljutic (bib14) 1998 Loon, Wilcox, Unwin (bib12) 1989; 36 Accessed December 11, 2009. Copeland, Campbell, Rlachetka, Salomon, Larson (bib5) 1983; 146 Copeland (10.1016/j.cardfail.2009.11.005_bib5) 1983; 146 Loon (10.1016/j.cardfail.2009.11.005_bib12) 1989; 36 Pivac (10.1016/j.cardfail.2009.11.005_bib14) 1998 Kramer (10.1016/j.cardfail.2009.11.005_bib15) 1996; 36 Dormans (10.1016/j.cardfail.2009.11.005_bib7) 1996; 28 Domanski (10.1016/j.cardfail.2009.11.005_bib3) 2003; 42 Gulbis (10.1016/j.cardfail.2009.11.005_bib6) 2006; 40 10.1016/j.cardfail.2009.11.005_bib8 Fonarow (10.1016/j.cardfail.2009.11.005_bib2) 2003; 4 (10.1016/j.cardfail.2009.11.005_bib4) 2006; 12 Felker (10.1016/j.cardfail.2009.11.005_bib9) 2009; 2 Ellison (10.1016/j.cardfail.2009.11.005_bib10) 2001; 96 Aaser (10.1016/j.cardfail.2009.11.005_bib16) 1997; 57 Hammarlund (10.1016/j.cardfail.2009.11.005_bib11) 1985; 233 Lahav (10.1016/j.cardfail.2009.11.005_bib13) 1992; 102 10.1016/j.cardfail.2009.11.005_bib1 |
| References_xml | – reference: Salvador DRK, Rey NR, Ramos GC, Punzalan FER. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003178. DOI: 10.1002/14651858.CD003178.pub3 – reference: . Accessed December 11, 2009. – volume: 4 start-page: S21 year: 2003 end-page: S30 ident: bib2 article-title: Acute Decompensated Heart Failure National Registry (ADHERE) Advisory Committee. The acute decompensated heart failure national registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure publication-title: Rev Cardiovasc Med – volume: 102 start-page: 725 year: 1992 end-page: 731 ident: bib13 article-title: Intermittent administration of furosemide versus continuous infusion preceded by a loading dose for congestive heart failure publication-title: Chest – volume: 146 start-page: 796 year: 1983 end-page: 799 ident: bib5 article-title: Diuresis with continuous infusion of furosemide after cardiac surgery publication-title: Am J Surg – volume: 96 start-page: 132 year: 2001 end-page: 143 ident: bib10 article-title: Diuretic therapy and resistance in congestive heart failure publication-title: Cardiology – volume: 233 start-page: 447 year: 1985 end-page: 453 ident: bib11 article-title: Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling publication-title: J Pharmacol Exp Ther – volume: 36 start-page: 265 year: 1996 end-page: 270 ident: bib15 article-title: Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion with congestive heart failure publication-title: J Clin Pharm – volume: 12 start-page: e86 year: 2006 end-page: 103 ident: bib4 article-title: Evaluation and management of patients with acute decompensated heart failure publication-title: J Card Fail – volume: 42 start-page: 705 year: 2003 end-page: 708 ident: bib3 article-title: Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD) publication-title: J Am Coll Cardiol – start-page: 121 year: 1998 end-page: 128 ident: bib14 article-title: Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure publication-title: Int J Clin Pharm Res – volume: 36 start-page: 682 year: 1989 end-page: 689 ident: bib12 article-title: Mechanism of impaired natriuretic response to furosemide during prolonged therapy publication-title: Kidney Intl – volume: 2 start-page: 56 year: 2009 end-page: 62 ident: bib9 article-title: Loop diuretics in acute decompensated heart failure, necessary? evil?, a necessary evil? publication-title: Circ Heart Fail – volume: 40 start-page: 1797 year: 2006 end-page: 1803 ident: bib6 article-title: Efficacy and safety of a furosemide continuous infusion following cardiac surgery publication-title: Ann Pharmacother – volume: 57 start-page: 361 year: 1997 end-page: 368 ident: bib16 article-title: Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure publication-title: Scand J Clin Lab Invest – volume: 28 start-page: 376 year: 1996 end-page: 382 ident: bib7 article-title: Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion publication-title: J Am Coll Cardiol – reference: American Heart Association, American Stroke Association. Heart disease and stroke statistics—2008 update. Available from: – volume: 57 start-page: 361 year: 1997 ident: 10.1016/j.cardfail.2009.11.005_bib16 article-title: Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure publication-title: Scand J Clin Lab Invest doi: 10.3109/00365519709099409 – volume: 36 start-page: 682 year: 1989 ident: 10.1016/j.cardfail.2009.11.005_bib12 article-title: Mechanism of impaired natriuretic response to furosemide during prolonged therapy publication-title: Kidney Intl doi: 10.1038/ki.1989.246 – volume: 2 start-page: 56 year: 2009 ident: 10.1016/j.cardfail.2009.11.005_bib9 article-title: Loop diuretics in acute decompensated heart failure, necessary? evil?, a necessary evil? publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.108.821785 – volume: 12 start-page: e86 year: 2006 ident: 10.1016/j.cardfail.2009.11.005_bib4 article-title: Evaluation and management of patients with acute decompensated heart failure publication-title: J Card Fail doi: 10.1016/j.cardfail.2005.11.017 – volume: 96 start-page: 132 year: 2001 ident: 10.1016/j.cardfail.2009.11.005_bib10 article-title: Diuretic therapy and resistance in congestive heart failure publication-title: Cardiology doi: 10.1159/000047397 – volume: 40 start-page: 1797 year: 2006 ident: 10.1016/j.cardfail.2009.11.005_bib6 article-title: Efficacy and safety of a furosemide continuous infusion following cardiac surgery publication-title: Ann Pharmacother doi: 10.1345/aph.1G693 – volume: 146 start-page: 796 year: 1983 ident: 10.1016/j.cardfail.2009.11.005_bib5 article-title: Diuresis with continuous infusion of furosemide after cardiac surgery publication-title: Am J Surg doi: 10.1016/0002-9610(83)90344-6 – volume: 28 start-page: 376 year: 1996 ident: 10.1016/j.cardfail.2009.11.005_bib7 article-title: Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(96)00161-1 – volume: 233 start-page: 447 year: 1985 ident: 10.1016/j.cardfail.2009.11.005_bib11 article-title: Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)21252-6 – volume: 102 start-page: 725 year: 1992 ident: 10.1016/j.cardfail.2009.11.005_bib13 article-title: Intermittent administration of furosemide versus continuous infusion preceded by a loading dose for congestive heart failure publication-title: Chest doi: 10.1378/chest.102.3.725 – ident: 10.1016/j.cardfail.2009.11.005_bib1 – volume: 42 start-page: 705 year: 2003 ident: 10.1016/j.cardfail.2009.11.005_bib3 article-title: Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD) publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)00765-4 – volume: 4 start-page: S21 issue: Suppl 7 year: 2003 ident: 10.1016/j.cardfail.2009.11.005_bib2 article-title: Acute Decompensated Heart Failure National Registry (ADHERE) Advisory Committee. The acute decompensated heart failure national registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure publication-title: Rev Cardiovasc Med – start-page: 121 year: 1998 ident: 10.1016/j.cardfail.2009.11.005_bib14 article-title: Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure publication-title: Int J Clin Pharm Res – ident: 10.1016/j.cardfail.2009.11.005_bib8 doi: 10.1002/14651858.CD003178.pub3 – volume: 36 start-page: 265 year: 1996 ident: 10.1016/j.cardfail.2009.11.005_bib15 article-title: Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion with congestive heart failure publication-title: J Clin Pharm doi: 10.1002/j.1552-4604.1996.tb04197.x |
| SSID | ssj0008407 |
| Score | 2.1926427 |
| Snippet | Despite advances in the treatment of chronic ambulatory heart failure, hospitalization rates for acute decompensated heart failure (ADHF) remain high. Although... Abstract Background Despite advances in the treatment of chronic ambulatory heart failure, hospitalization rates for acute decompensated heart failure (ADHF)... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 188 |
| SubjectTerms | Acute Disease Adolescent Adult Aged Aged, 80 and over Cardiovascular Chi-Square Distribution Diuretics Dose-Response Relationship, Drug Drug Administration Schedule Female Follow-Up Studies furosemide Furosemide - administration & dosage Furosemide - adverse effects heart failure Heart Failure - diagnosis Heart Failure - drug therapy Humans Infusions, Intravenous - methods Injections, Intravenous - methods Male Middle Aged Probability Prospective Studies Risk Assessment Severity of Illness Index Sodium Potassium Chloride Symporter Inhibitors - administration & dosage Sodium Potassium Chloride Symporter Inhibitors - adverse effects Treatment Outcome Young Adult |
| Title | Continuous Versus Intermittent Infusion of Furosemide in Acute Decompensated Heart Failure |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1071916409011919 https://www.clinicalkey.es/playcontent/1-s2.0-S1071916409011919 https://dx.doi.org/10.1016/j.cardfail.2009.11.005 https://www.ncbi.nlm.nih.gov/pubmed/20206891 https://www.proquest.com/docview/733158037 |
| Volume | 16 |
| WOSCitedRecordID | wos000277582100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: ScienceDirect customDbUrl: eissn: 1532-8414 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0008407 issn: 1071-9164 databaseCode: AIEXJ dateStart: 19950301 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JbtswECWcpCh6Kbqm7hLw0JuhlFpoikfXseF0MYI2LYxeBIoSAQW2YlhykF_vrUORtB0kTtMAvXgRSJmeeZoZksM3CL0nRHYFZamnSSe9SBHuCV8IT0Yi65JUiG7DePPzCxuP48mEn7Rav91ZmIspK8v48pLP_6uq4RooWx-d_Qd1r24KF-AzKB1eQe3weifFa76polzq1Fa9GAZvzarfrKhrve9_XKplZaPEoeayzGdF1jCH9KTOGTjKdZY5TG6FjkVHIJ26MxTF1DKP3BDIygZksqM2WtlUE3ucy1XT7Xw7NIs4YjE7apDVX1e4Hov5vDAJN3oD6ZaWLug2Fdk6J7c0HWnOcWMI4aYft7W0yx56x97lfVlLDbERWGpDgb4y5d0NyIYbdtk3tQOti_dNUcZr3sMsZJwdarlpmRk6U03ySujaX7ocgUH_s-9VwSHxvuvB6LEQfZCXWx9wlcbbT6ogIcm1pjtoL2CUg0_Z6x0PJp9WYQTMvJlJmDX_c-N4-80j3BZZbZs5NRHU6RP02CIG9wxkn6JWXj5DD7_a5I7n6NcaudggF28iFzvk4nOF18jFRYkb5OIryMUNcrFF7gv0Yzg47Y88W_oDjARjtcch6s-VVGkGX1NFVU5iGYvIz7MwC7JIEiZ4KrgUoMuYwpyEpmnIwoinirM0C1-i3fK8zF8hTAMqFc1VqiSJFI05IyoLIiapkFz5pI2oE1siLS--Ls8yTVwC5FnixK2LtnKYNCcg7jb6sOo3N8wwf-3BnFYSd-4ZPHUC8Ltfz7yydqdKtsGrjfiqp42pTax8p1_FDjoJOB29kyjKHECQ6EKvNCYha6N9A6mVCAKYf3Zj7r--95DfoEfrB_4t2q0Xy_wdeiAv6qJaHKAdNokP7MPyB94fAqg |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Continuous+Versus+Intermittent+Infusion+of+Furosemide+in+Acute+Decompensated+Heart+Failure&rft.jtitle=Journal+of+cardiac+failure&rft.au=Thomson%2C+Margaret+R.%2C+PharmD%2C+BCPS&rft.au=Nappi%2C+Jean+M.%2C+PharmD%2C+BCPS&rft.au=Dunn%2C+Steven+P.%2C+PharmD%2C+BCPS&rft.au=Hollis%2C+Ian+B.%2C+PharmD%2C+BCPS&rft.date=2010-03-01&rft.issn=1071-9164&rft.volume=16&rft.issue=3&rft.spage=188&rft.epage=193&rft_id=info:doi/10.1016%2Fj.cardfail.2009.11.005&rft.externalDBID=ECK1-s2.0-S1071916409011919&rft.externalDocID=1_s2_0_S1071916409011919 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10719164%2FS1071916410X00033%2Fcov150h.gif |